Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron Pharmaceuticals, Inc. FCF to Net Income
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCF to Net Income | (55.4%) | 36.9% | (19.8%) | (8.5%) | 149.9% | 250.0% | 3.2% | 89.7% | (16.5%) | 101.9% | 120.5% | 102.6% | 108.8% | 86.3% | 74.1% | 94.5% | 57.0% | 80.9% | 102.0% | 92.8% |
Regeneron Pharmaceuticals, Inc. (REGN) FCF to Net Income comparison analysis
REGN key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Regeneron Pharmaceuticals, Inc.'s FCF to Net Income?
As of today, Microsoft Corp's last 12-month FCF to Net Income is 72.6%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual FCF to Net Income for Regeneron Pharmaceuticals, Inc. have been 87.8% over the past three years, and 88.4% over the past five years.
2) Is Regeneron Pharmaceuticals, Inc.'s FCF to Net Income Good?
As of today, Regeneron Pharmaceuticals, Inc.'s FCF to Net Income is 72.6%, which is lower than industry median of 83.9%. It indicates that Regeneron Pharmaceuticals, Inc.'s FCF to Net Income is Bad.